Amicus Therapeutics (FOLD) Misses Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Qualcomm investor day to detail data center plans Wednesday
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
